suPAR at Congresses & Conferences
The ViroGates team visits a variety of scientific and commercial congresses every year.For 2013 the following events are planned:
2014:
June 11-14, Hong Kong, China
ICEM 2014 – International Conference on Emergency Medicine (www.icem2014.org)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
2013:
November 20-23, Düsseldorf, Germany
MEDICA – World Forum for Medicine (www.medica-tradefair.com)Jakob Knudsen, CEO, Helle Fisker, VP Sales & Marketing, and Claus Berner, Senior Consultant, will be present to discuss business opportunities.
September 24-26, Twickenham, London, United Kingdom
2013 CEM Annual Scientific Conference – College of Emergency Medicine (www.collemergencymed.ac.uk)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
September 8-11, Marseille, France
7'th MEMC – Mediterranean Emergency Medicine Congress (www.memc2013.org)
Jakob Knudsen, CEO and Helle Fisker, VP Sales & Marketing will be present to discuss business opportunities.
June 10-12, Tel Aviv, Israel
IATI-BioMed Israel 2013 Conference (www2.kenes.com)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
June 10-12, London, United Kingdom
Anglonordic Medtech Conference (www.anglonordicmedtech.com)
Jakob Knudsen, CEO, will be present to discuss business opportunities.
May 28, Leuven, Belgium
Mini-symposium "Urgentiegeneeskunde" 13.30 at UZ Leuven, Auditorium Renaer
Jolanda Jacobs from EliTech, our distributor in Belgium, will be there to present suPARnostic® Quick Triage
May 6-7, Berlin, Germany
XI. BIONNALE 2013 (www.biotop.de)
Jakob Knudsen, CEO, will be there as a speaker and to discuss business opportunities.
April 25-26, Manchester, United Kingdom
10'th Annual Critical Care Symposium (www.critcaresymposium.co.uk)
Jakob Knudsen, CEO, and Jesper Eugen-Olsen, will be there as speakers and to discuss business opportunities.
March 19-22, Brussels, Belgium
33'rd ISICEM - International Symposium of Intensive Care and Emergency Medicine (www.intensive.org)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
March 9-11, San Francisco, USA
ACC.13 - Discovery to Delivery; Transformation of Cardiovascular Care
suPAR poster from Emory Clinical Cardiovascular Research Institute presented:
suPAR is an Independent Predictor of Cardiovascular Outcomes in Patients with Left Ventricular Systolic Dysfunction
March 5-6, Zurich, Switzerland
6'th Annual European Life Science CEO Forum (www.sachsforum.com/zurich_elsceo13)
Jakob Knudsen, CEO, will be present to discuss business opportunities.
February 25-26, Aachen, Germany
4´th International suPAR Symposium (www.suparnostic.com/supar-symposium-2013)
"New horizons for suPAR: Risk stratification, organ dysfunction and relevance for specific diseases"
Hosted by The University Hospital Aachen, Germany and sponsored by ViroGates.
Jakob Knudsen, CEO, Helle Fisker, VP Sales & Marketing and Claus Berner, Senior Consultant, are looking forward to meeting you.
February 12, Zurich, Switzerland
7'th Swiss-Scandinavian Bio-Business Seminar (www.ssbbs2013.com)
Jakob Knudsen, CEO, will be present to discuss business opportunities.
2012:
November 14-17, Dusseldorf, Germany
MEDICA - World Forum for Medicine (www.medica-tradefair.com)
Jakob Knudsen, CEO, Helle Fisker, VP Sales & Marketing, and Claus Berner, Senior Consultant, will be present to discuss business opportunities.
November 12-14, Hamburg, Germany
BIO-Europe 2012 - 18´th Annual International Partnering Conference (www.ebdgroup.com/bioeurope)
Jakob Knudsen, CEO, will be present Nov. 12-13 to discuss business opportunities.
November 7-9, Paris, France
Sepsis 2012 (www.sepsisforum.org/sepsisconferences)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
November 3-7, Los Angeles, California, USA
American Heart Association: Scientific Sessions 2012
Presentation of Abstract:
Nov. 6, 9.30 - 11.00, Kentia Hall: "Elevated Levels of Plasma Soluble Urokinase Plasminogen Activator Receptor is an Independent Predictor of Coronary Microvascular Dysfunction "
Nov. 7, 9.30 - 11.00, Kentia Hall:"Association of Depression with Soluble Urokinase- Type Plasminogen Activator Receptor and Other Markers of Inflammation and Immunity "
Nov. 7, 10.45 - 11.00, Hall A-10:"Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Presence and Severity of Coronary Disease and is an Independent Predictor of Adverse Cardiovascular Outcomes"
October 22-26, Miami, Florida, USA
TCT2012
Oral presentation of Abstract:
Oct. 23, 10.00 - 12.00: "Elevated Levels of Plasma Soluble Urokinase Plasminogen Activator Receptor is an Independent Predictor of Coronary Microvascular Dysfunction"
October 13-17, Lisbon, Portugal
25´th ESICM LIVES 2012 - Annual Congress of the European Society of Intensive Care Medicine (www.esicm.org)
Claus Berner, Senior Consultant, will be present to discuss business opportunities.
October 3-6, Antalya, Turkey
EuSEM 2012 - 7´th European Congress on Emergency Medicine (www.eusem2012.org)
Claus Berner, Senior Consultant, will be present to discuss business opportunities.
October 1-2, Zurich, Switzerland
12´th Annual Biotech in Europe Investor Forum (www.sachsforum.com)
Jakob Knudsen, CEO, will be participating Oct. 1-2, and will be presenting on Oct. 2 at 12.45 - 13.00 in Panorama B; Company Presentations.
September 19-22, Budapest, Hungary
SepsEast 2012 - 1´st Central and Eastern European Sepsis Forum (www.sepseast.eu)
Oral presentation by Dr. Malgorzata Mikaszewska Sokolewicz, Poland on Sept. 20 at 11.25: "suPAR - prognostic marker in severe sepsis"
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
September 12-14, Udine, Italy
62´nd NATIONAL MEETING AIPaCMeM - Italian Association of Clinical Pathology and Molecular Medicine
"Inflammation: from the Basics of General Pathology to Personalized Medicine"
Douglas Swannie, S.R.L., ViroGates distributor in Italy, will have a booth and host a lunch workshop on suPAR with Casagranda and Arfini (Alessandria) and Tognoli (Tumor Institute of Milan) on Sept. 13 at 13.00-14.00.
June 27-30, Dublin, Ireland
14´th ICEM - International Conference on Emergency Medicine (www.icem2012.org)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
June 18-21, Boston, USA
2012 BIO International Convention (www.convention.bio.org)
Jørgen Thorball, Chairman of the Board, ViroGates, will be present to discuss business opportunities.
June 13-15, Oviedo, Spain
XXIV Congreso Nacional de SEMES - The Spanish Association of Emergency Medicine (www.semes.org)
Claus Berner, Senior Consultant, will be present to discuss business opportunities.
June 10-13, Santander, Spain
XLVII Congreso Nacional de la SEMICYUC - The Spanish Association for Intensive Care Medicine & Coronary Units (www.semicyuc.org)
Jesús Ramos, ViroGates distributor in Spain, will be present to discuss business opportunities.
June 7-8, Paris, France
2´nd Paris International Conference on Intensive Care, SRLF (www.pic-srlf.fr)
"Understanding the 2012 Surviving Sepsis Campaign guidelines"
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
May 31 - June 1, Grenoble, France
EuroMedtech 2012 - 4´th Annual International Medtech Partnering Conference (www.ebdgroup.com/emt)
Jakob Knudsen, CEO, will give a corporate presentation of ViroGates.
May 29-30, Helsinki, Finland
Acute Kidney Injury and Sepsis Symposium (www.sny.fi/nefro)
Oral presentation by Dr. Jesper Eugen-Olsen, Principal Investigator, Copenhagen University Hospital, Hvidovre, Denmark on May 30, 10.00-10.20: "suPAR in critically ill patients with sepsis and AKI"
May 23, London, United Kingdom
Anglonordic Medtech Conference (www.anglonordicmedtech.com)
Jakob Knudsen, CEO, will give a corporate presentation of ViroGates.
April 26-27, Manchester, United Kingdom
9´th Annual Critical Care Symposium (www.critcaresymposium.co.uk)
Helle Fisker, VP Sales & Marketing, will be present to discuss business opportunities.
March 20-23, Brussels, Belgium
32´nd ISICEM - International Symposium on Intensive Care and Emergency Medicine (www.intensive.org)
Jakob Knudsen, CEO, wil be present to discuss business opportunities.
February 27-28, Copenhagen, Denmark
3´nd International suPAR Symposium (www.conferencemanager.dk/suPAR2012)
"Discussion of the features and potential usability of the suPAR protein as a biomarker"
Hosted by Copenhagen University Hospital, Hvidovre, Denmark and sponsored by ViroGates.
Jakob Knudsen, CEO, and Claus Berner, VP Sales & Marketing are looking forward to meeting you.
